HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Clinical trial of diflucortolone. Preliminary report].

Abstract
Diflucortolone valerianate, a new fluorinated corticosteroid for tropical use, was applied in 52 patients suffering of diverse inflammatory dermatosis. The maximum observation time was 3 weeks. The results were, very good in 63.46%; good in 28.84%; regular in 1.92 %, and bad in 5.76%. In 73.7% of the cases good results were obtained in less than 2 weeks. The cream was cosmetically well accepted and there were no observed side effects.
AuthorsE Hernańdez-Peŕez
JournalMedicina cutanea ibero-latino-americana (Med Cutan Ibero Lat Am) Vol. 9 Issue 3 Pg. 229-32 ( 1981) ISSN: 0210-5187 [Print] Portugal
Vernacular TitleEnsayo clínico de la diflucortolona. Reporte preliminar.
PMID7026942 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Ointments
  • diflucortolone valerate
  • Fluocortolone
  • Diflucortolone
Topics
  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Dermatitis (drug therapy)
  • Diflucortolone (administration & dosage, analogs & derivatives, therapeutic use)
  • Drug Evaluation
  • Fluocortolone (analogs & derivatives)
  • Humans
  • Infant
  • Middle Aged
  • Ointments

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: